Dr. Kim Lawson (B.Tech(Hons), PhD) is a Senior Lecturer in Pharmacology at Sheffield Hallam University, UK. He received a B.Tech in pharmacology from University of Bradford (UK) and a PhD in pharmacology from the University of Sunderland (UK) and has an international reputation in Drug Discovery Research, gained in multinational pharmaceutical industries (France: Rhone-Poulenc Sante, Recherche Syntex France; Belgium: Sanofi-Labaz; UK: Reckitt & Colman, British Biotech) and academia. His research interests are focused on the pharmacology of potassium channels and to the identification of pharmacological treatments of fibromyalgia. Kim is regularly invited as a consultant to the pharmaceutical and healthcare industries & affiliated organizations, to talk at public events & scientific conferences and to write 'expert opinion' articles for scientific and clinical journals. He is chair of the Medical Advisory Board of Fibromyalgia Action UK and Patron to Folly Pogs Fibromyalgia Research UK.
Fibromyalgia; potassium channel pharmacology.